This webinar provides practical guidance, debunks common perceptions around adverse event (AE) management, and highlights real-world case studies covering both acute and long-term monitoring. Gain insights into patient experience, early intervention strategies, and confident AE management.
By the end of this webinar, participants should be able to:
- Understand oral therapy and monitoring essentials specific to Zejula® in ovarian cancer.
- Apply proactive approaches to adverse event management.
- Analyse case studies to explore real-world management of side effects and long-term monitoring success.
- Educate and support patients in managing their own care and recognising when to report symptoms.
- Utilise practical tools and strategies to optimise outcomes for patients on oral ovarian cancer therapies.